Institut Català d'Oncologia (ICO)

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-10-05		NCT06582628

Clinical trials